DiscoveRx

DiscoveRx Enzyme Fragment Complementation (EFC) technology is a proven, established screening technology and the EFC-based HitHunter™ cAMP assays are the market leader in GPCR screening applications. PathHunter™ technology, an adaptation of EFC technology, is an innovative and comprehensive assay system that enables live cell-based assays for pathway profiling and screening. Through the core HitHunter™, PathHunter™, and EFC technologies, DiscoveRx is able to offer assay solutions for every major class of drug target, including GPCRs, kinases, proteases, nuclear hormone receptors, transcription factors, and secreted proteins. To view a complete list of products and technologies available through DiscoveRx, please click here.

The co-marketing agreement with DiscoveRx allows Evotec to combine these technologies with Evotec's proprietary technologies and know-how in high throughput screening. This means that Evotec can offer unrivalled screening solutions within the drug discovery process for GPCRs and other important target classes.